# Summit Biosciences Inc.: Form D filing

Summit Biosciences Inc., a pharmaceuticals company in Lexington, KY, filed a Form D with the SEC in 2013. The latest, on May 2, 2013, reports an offering of $750,000 with nothing sold yet.

Find out what Summit Biosciences Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20Summit%20Biosciences%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=Summit%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsummit-biosciences-inc-1575898)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20Summit%20Biosciences%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=Summit%20Biosciences%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fsummit-biosciences-inc-1575898)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky): 216 rows, by operating companies, filed since November 1, 2024, $10.80, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/kentucky
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1513 BULL LEA ROAD, Lexington, KY, 40511
- Phone: (859) 254-0180
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2009
- Revenue range: $1,000,001 - $5,000,000
- Exemptions claimed: Rule 506
- SEC identifier (CIK): 1575898

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 2, 2013 | New notice | $750,000 | $0 | $750,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1575898/000091195913000017/0000911959-13-000017-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Richard A. Cohen | Director |  |
| Charles A. Moyer | Director |  |
| Sonia L. Egbert | Executive Officer |  |
| William A. Lomicka | Director |  |
| Edwin A. Cohen | Executive Officer, Director |  |
| Greg Plucinski | Executive Officer |  |
| Robert A. Saunders | Director |  |

[Every Form D from the week of Apr 29, 2013](https://specstream.ai/data/form-d/week/2013-04-29) · [All recent filings in Kentucky](https://specstream.ai/data/form-d/state/kentucky) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what Summit Biosciences Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).